Dr. Nilay Mehta, DO

Dr. Mehta practices at Mehta Medical Group in Humble, Texas.

Dr. Mehta's NPI, 1225295132, was assigned on May 19, 2008. Dr. Mehta graduated from Chicago College of Osteopathic Medicine at Midwestern University in 2008. Dr. Mehta holds Texas license N6926.

Dr. Mehta's primary practice is Mehta Medical Group, at 18955 N Memorial Dr, Humble, TX 77338 in Harris County. The practice phone is (281) 446-7173.

Dr. Mehta's primary practice is Mehta Medical Group in Humble, Texas. Dr. Mehta is also affiliated with Memorial Hermann Northeast Hospital. The medical group on file is Wellspire Medical Group. Dmand AI also links Dr. Mehta to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Mehta is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Mehta is licensed in Texas.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cerebrovascular disease, chronic hypertension, chronic skin ulcer and coronary artery disease among the conditions Dr. Mehta treats.

CMS data shows 4,091 Medicare services from Dr. Mehta across 28 procedure codes in 2024, for 1,404 Medicare patients. Medicare paid $213,510 for them.

CMS counts 1,404 Medicare patients who saw Dr. Mehta in 2024. The largest group is 75 to 84, with 541 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 69, with 50% women.

In 2024, Dr. Mehta wrote 4,059 Medicare Part D claims for 559 patients. 90% of them were for generic drugs. CMS names the drug for 3,878 of them, across 51 drugs with 11 or more claims each, at $439,751 in total drug cost. In 2023, CMS named 3,633 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Mehta for performance year 2024, reported individually. Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Mehta, published from 2012 to 2013. 2012 was the busiest year, with 2. Dr. Mehta's most frequent co-authors are Salman Jamaluddin Bandeali, MD, Yochai Birnbaum, MD and Nilay Virendrakumar Mehta, MD.

CMS Open Payments shows 377 general payments to Dr. Mehta from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Biotronik Inc. paid the most, $5,178.

Dr. Mehta graduated from Chicago College of Osteopathic Medicine at Midwestern University in 2008.

Dr. Mehta is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.